Indonesia’s policy misstep is Vietnam’s opportunity to seize the sweet spot as Southeast Asia’s pharmaceutical hub

//Indonesia’s policy misstep is Vietnam’s opportunity to seize the sweet spot as Southeast Asia’s pharmaceutical hub

Indonesia’s policy misstep is Vietnam’s opportunity to seize the sweet spot as Southeast Asia’s pharmaceutical hub

Vietnam will be the biggest pharmaceutical market in Southeast Asia in less than a decade. Domestic and biotech joint ventures in Vietnam are on track to rescue the Indian market as well as become a major supplier and R&D hub for Japanese biomedical firms.Additionally, by coordinating with Vietnamese tech entrepreneurs, medicine verification apps for affordable Vietnamese drugs will dominate the scandal-plagued Chinese market.By continuing to strengthen its intellectual property protections,…

Article by [author-name] (c) South China Morning Post - Read full story here.

By | 2019-02-24T09:18:59+00:00 February 24th, 2019|Business|Comments Off on Indonesia’s policy misstep is Vietnam’s opportunity to seize the sweet spot as Southeast Asia’s pharmaceutical hub